Man accused of killing Campbell Clinic doctor due in court
A man accused of shooting and killing a doctor in an exam room back in 2023 is scheduled to appear in court on Monday morning.
UTHSC In the Media
Erlanger celebrates those committed to its success
Erlanger welcomed physicians, community leaders and supporters to its 22nd Annual Dinner of Distinction Feb. 6 at The Westin Chattanooga, honoring four individuals whose careers and service have left a lasting imprint on health care across the region.
UT Health Science Center hires super star
New research from the University of Tennessee Health Science Center suggests that proposed front-of-package nutrition labels could help Americans better identify healthier foods but may not work equally well for all consumers.
Research from UT Health Sciences Adds Insight to FDA Nutrition Label Proposal
Yuru Huang, PhD, was on a research team that published a study in the American Journal of Preventive Medicine examining the FDA’s proposed front-of-package nutrition label.
$3.2m project targets aggressive MDM2 in breast cancer
A University of Houston scientist has joined a $3.2 million research collaboration to develop a new drug targeting one of the key drivers of triple-negative breast cancer.
Researchers Develop Novel Treatment Option for Triple Negative Breast Cancer
A researcher at the University of Houston College of Pharmacy has joined a $3.2 million effort to develop a promising new treatment for triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of the disease, accounting for 10-15% of all breast cancer cases.
UH Researcher Part of $3.2M Initiative to Develop Innovative Breast Cancer Therapy
A groundbreaking development in the treatment of triple-negative breast cancer (TNBC) is emerging from a collaborative research initiative involving the University of Houston and the University of Tennessee Health Science Center.
UH Researcher Part of $3.2M Initiative to Develop Innovative Breast Cancer Therapy
A groundbreaking development in the treatment of triple-negative breast cancer (TNBC) is emerging from a collaborative research initiative involving the University of Houston and the University of Tennessee Health Science Center.